"10.1371_journal.pone.0003960","plos one","2008-12-18T00:00:00Z","Meta Roestenberg; Ed Remarque; Erik de Jonge; Rob Hermsen; Hildur Blythman; Odile Leroy; Egeruan Imoukhuede; Soren Jepsen; Opokua Ofori-Anyinam; Bart Faber; Clemens H M Kocken; Miranda Arnold; Vanessa Walraven; Karina Teelen; Will Roeffen; Quirijn de Mast; W Ripley Ballou; Joe Cohen; Marie Claude Dubois; St√©phane Ascarateil; Andre van der Ven; Alan Thomas; Robert Sauerwein","Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Biomedical Primate Research Centre, Rijswijk, The Netherlands; European Malaria Vaccine Initiative, Copenhagen, Denmark; GlaxoSmithKline Biologicals, Rixensart, Belgium; SEPPIC, Paris, France","Conceived and designed the experiments: EJR HEB OL SJ OOA BWF WRB JC MCD AVdV AWT RWS. Performed the experiments: MR EJR ECCdJ CH MA VW KT WR QdM AVdV. Analyzed the data: MR CH EBI. Contributed reagents/materials/analysis tools: EJR CH OOA BWF CHK SA. Wrote the paper: MR EJR CH EBI OOA MCD AVdV AWT RWS.","AS02 is the proprietary Adjuvant System from GlaxoSmithKline Biologicals, which might pose a conflict of interest to associated authors. Other authors do not have a commercial or other association that might pose a conflict of interest.","2008","12","Meta Roestenberg","MR",23,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
